Lance Leopold

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence

Richard A. Larson, Eric L. Sievers, Edward A. Stadtmauer et al. · Cancer · 2005 · 458 citations

Medicine, Hematology, Pharmacology +17

Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)

Tara C. Mitchell, Omid Hamid, David C. Smith et al. · Journal of Clinical Oncology · 2018 · 385 citations · Full text

Medicine, Oncology, Pharmacology +17

First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies

Gregory L. Beatty, Peter J. O’Dwyer, Jason Clark et al. · Clinical Cancer Research · 2017 · 318 citations · Full text

Medicine, Oncology, Pharmacology +14

Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed

Herbert I. Hurwitz, Nikhil Uppal, Stephanie A. Wagner et al. · Journal of Clinical Oncology · 2015 · 287 citations · Full text

Medicine, Oncology, Pharmacology +16

A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment

Qian Cai, Haiying Sun, Yuefeng Peng et al. · Journal of Medicinal Chemistry · 2011 · 267 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17